迈克生物公告，公司近日获得国家药品监督管理局颁发的医疗器械注册证书，涉及两款体外诊断试剂产品：人不规则抗体检测红细胞试剂盒和肺炎支原体IgM抗体检测试剂盒。注册证有效期为2025年6月20日至2030年6月19日。这些新产品进一步丰富了公司产品线，有助于提升市场竞争力并推动市场拓展。公司在直接化学发光平台下已累计取得133项试剂类产品注册证书，覆盖多种病种检测。新产品的市场表现尚需观察。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.